![Manuel Schweikle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Manuel Schweikle active positions
Companies | Position | Start | End |
---|---|---|---|
Nordovo Biosciences AS
![]() Nordovo Biosciences AS BiotechnologyHealth Technology Nordovo Biosciences AS, operating under the name clexbio, is a pre-clinical stage biotech company based in Oslo, Norway. The Norwegian company is focused on developing next-generation tissue-engineered allogeneic grafts for transplant, using its proprietary platform technologies clex and vivoset. clexbio combines advanced bio-fabrication approaches with its proprietary hydrogel technology clex to create breakthrough solutions for tissue engineering and single-cell techniques. The private company was founded by Manuel Schweikle and Armend G. Håti, with Armend G. Håti serving as CEO since incorporation. | Chief Tech/Sci/R&D Officer | 2020-03-31 | - |
Founder | - | - |
Career history of Manuel Schweikle
Statistics
International
Norway | 2 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Nordovo Biosciences AS
![]() Nordovo Biosciences AS BiotechnologyHealth Technology Nordovo Biosciences AS, operating under the name clexbio, is a pre-clinical stage biotech company based in Oslo, Norway. The Norwegian company is focused on developing next-generation tissue-engineered allogeneic grafts for transplant, using its proprietary platform technologies clex and vivoset. clexbio combines advanced bio-fabrication approaches with its proprietary hydrogel technology clex to create breakthrough solutions for tissue engineering and single-cell techniques. The private company was founded by Manuel Schweikle and Armend G. Håti, with Armend G. Håti serving as CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Manuel Schweikle
- Experience